Review Article
The Role of Protein Arginine Methyltransferases in Inflammatory Responses
Table 3
Regulatory mechanisms of PRMTs.
(a) PTMs: PRMT activities are modulated by PTMs |
| PRMTs | Types of PTM | Enzymes involved in PTM | Biological role of PTM | Reference |
| CARM1 | Phosphorylation at S217 | Unidentified kinase | Activating by regulation to bind with AdoMet | [21, 22] | Glycosylation | N-acetylglucosamine transferase (OGT) | Activating by controlling the phosphorylation of CARM1 | [23, 24] | Auto-arginine methylation | Unidentified | Unclear | [25] |
| PRMT5 | Amino-terminal phosphorylation | Janus kinase 2 (JAK2) | Inactivating via blocking the interaction between PRMT5 and methylosome protein 50 (MEP50) | [26] |
| PRMT6 and PRMT8 | Auto-arginine methylation | Unidentified | Unclear | [27, 28] |
|
|
(b) Regulatory partner: interaction with regulatory proteins can control the activity of PRMTs |
| PRMTs | Regulatory partner | Biological role | Reference |
| PRMT5 | MEP50 | Required for PRMT5 activation | [29] | SWI/SNF chromatin complex | Elevates the activity of MEP50-PRMT5 toward histone substrates | [30] | Exon junction complex component and RNA-binding protein Y14 | Enhances MEP50-PRMT5 activity toward Sm proteins | [31] |
| PRMT1 | Orphan nuclear receptor TR3 (NR4A1) | Inhibits PRMT1 enzyme activity | [32] | BTG1-binding chromatin assembly factor 1 (CAF1) | Negatively regulates PRMT1 activity | [33] | BTG1 | Increases PRMT1 activity | [34] | PRMT2 | Stimulates PRMT1 activation | [35] |
| PRMT3 | Tumor suppressor DAL1 | Blocks PRMT3 methyltransferase ability | [36] |
| PRMT7 | CCCTC-binding factor like (CTCFL) | Increases PRMT7 activity | [37] |
|
|
(c) miRNA regulation |
| PRMTs | Type of miRNA | Reference |
| PRMT5 | miR-19a, miR-25, miR-32, miR-92, miR-92b, and miR-96 | [38] |
|
|